Combination Chemotherapy in Treating Patients With Bladder Cancer



Status:Completed
Conditions:Cancer, Cancer, Cancer, Cancer, Bladder Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any - 120
Updated:1/3/2019
Start Date:March 1999
End Date:June 15, 2007

Use our guide to learn which trials are right for you!

A Phase III Randomized Trial of Either M-VAC or Paclitaxel + Carboplatin as Postoperative Adjuvant Therapy in Patients With Muscle-Invasive Transitional Cell Carcinoma of the Bladder at High-Risk for Relapse

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells. It is not
yet known whether four-drug combination chemotherapy is more effective than two-drug
combination chemotherapy in treating bladder cancer.

PURPOSE: Randomized phase III trial to compare the effectiveness of two combination
chemotherapy regimens in treating patients who have bladder cancer.

OBJECTIVES: I. Compare the recurrence rates and overall survival of patients treated with
postoperative adjuvant methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) to those
treated with combination paclitaxel and carboplatin for muscle invasive bladder cancer at
particularly high risk of relapse. II. Compare the relative toxicities of postoperative M-VAC
versus those encountered with postoperative paclitaxel and carboplatin. III. Compare the
quality of life scores during and following completion of treatment of patients in these two
treatment arms.

OUTLINE: This is a randomized study. Patients are stratified by N stage (N0 vs N+) and
performance status (0-1 vs 2). Patients are randomized to receive methotrexate, vinblastine,
doxorubicin, and cisplatin (arm I) or paclitaxel and carboplatin (arm II). Arm I: Patients
receive methotrexate IV push on days 1, 15, and 22; vinblastine IV push on days 2, 15, and
22; doxorubicin IV push on day 2; and cisplatin IV over 2 hours on day 2. Treatment repeats
every 28 days for 4 courses. Arm II: Patients receive paclitaxel IV over 3 hours on days 1
followed by carboplatin IV over 30 minutes on day 1. Treatment repeats every 21 days for 4
courses. Quality of life assessments are completed pretreatment, prior to course 3, 6 weeks
after the last dose of chemotherapy, and at 6, 12, and 24 months from the end of therapy.
Patients are followed every 3 months until year 2, every 6 months for years 2-5, and then
annually thereafter.

PROJECTED ACCRUAL: There will be 490 patients accrued into this study within 2.6 years.

DISEASE CHARACTERISTICS: Histologically confirmed transitional cell carcinoma of the
bladder or mixed histologies containing a component of transitional cell carcinoma Must
have undergone radical cystectomy and pelvic lymph node dissection within 12 weeks prior to
randomization No evidence of distant metastatic disease on pre- or postoperative
radiographic scans No positive surgical margins in the cystectomy specimen and no known
macroscopic residual disease left at time of cystectomy No bladder sparing surgery May have
undergone continent urinary diversion or neobladder procedure but must have recovered
completely from the effects of surgery Must have muscle-invasive disease on final
pathologic staging and have a primary tumor stage of pT4, any N, M0, or any pT, N+, M0, or
pT3b, any N, any M, and following a pelvic lymph node dissection have a pathologic nodal
stage of pN0 (only if pT3b or pT4), pN1, or pN2 Clinically unsuspected organ confined
prostate cancer found during cystoprostatectomy allowed

PATIENT CHARACTERISTICS: Age: Any age Performance status: ECOG 0-2 Life expectancy: Not
specified Hematopoietic: WBC at least 3,500/mm3 Platelet count at least 100,000/mm3
Hepatic: Bilirubin no greater than 1.5 times upper limit of normal (ULN) SGOT no greater
than 2 times ULN Renal: Creatinine no greater than 1.7 mg/dL OR Creatinine clearance at
least 60 mL/min Cardiovascular: No second degree atrioventricular block or bundle branch
block Other: No history of prior malignancy in the past 5 years except basal or squamous
cell carcinoma of the skin or carcinoma in situ of the cervix No active infection requiring
antibiotics No history of allergic reaction to drugs utilizing the vehicle Cremophor Not
pregnant or nursing Fertile patients must use effective contraception

PRIOR CONCURRENT THERAPY: Recovered from all prior therapies Biologic therapy: No prior
biologic response modifier therapy No filgrastim (G-CSF) 24 hours pre- or post-chemotherapy
administration Chemotherapy: No prior systemic chemotherapy Endocrine therapy: Not
specified Radiotherapy: No prior radiotherapy as a component of bladder sparing therapy No
prior adjuvant radiotherapy for locally advanced disease with positive margins Surgery: See
Disease Characteristics Other: Prior intravesical therapy for superficial bladder cancer
allowed and recovered
We found this trial at
13
sites
?
mi
from
New York, NY
Click here to add this to my saved trials
2010 E 90th St
Cleveland, Ohio 44195
(866) 223-8100
Cleveland Clinic Taussig Cancer Center At Taussig Cancer Institute, more than 250 highly skilled doctors,...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
?
mi
from
Decatur, GA
Click here to add this to my saved trials
Flemington, New Jersey 08822
?
mi
from
Flemington, NJ
Click here to add this to my saved trials
30 Prospect Ave
Hackensack, New Jersey 07601
(201) 996-2000
Hackensack University Medical Center Hackensack University Medical Center, part of the Hackensack University Health Network,...
?
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Indianapolis, Indiana 46202
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Millville, New Jersey 08332
?
mi
from
Millville, NJ
Click here to add this to my saved trials
175 Madison Avenue
Mount Holly, New Jersey 08060
(609) 914-6000
Fox Chase Cancer Center at Virtua Memorial Hospital of Burlington County Virtua Memorial is a...
?
mi
from
Mount Holly, NJ
Click here to add this to my saved trials
Nashville, Tennessee 37232
?
mi
from
Nashville, TN
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19102
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Red Bank, New Jersey 07701
?
mi
from
Red Bank, NJ
Click here to add this to my saved trials
99 Beauvoir Avenue
Summit, New Jersey 07902
(908) 522-2000
Overlook Hospital Atlantic Health System
?
mi
from
Summit, NJ
Click here to add this to my saved trials